Main Menu

Prometheus Biosciences, Inc.

(NASDAQ GS: RXDX)

Rigrodsky Law, P.A. is investigating Prometheus Biosciences, Inc. (“Prometheus”) regarding possible breaches of fiduciary duties and other violations of law related to Prometheus’ agreement to be acquired by Merck & Co., Inc. Under the terms of the agreement, Prometheus shareholders will receive $200.00 per share in cash.    

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/03/2023


* Indicates a required field.

Back to Page